FDA getting tougher with industry:
This article was originally published in Clinica
An additional sign that the FDA is stepping up its enforcement action against medical device companies emerged last week. One major Washington law firm, Hogan & Hartson, is currently working on three criminal cases brought by FDA investigators against device firms. At one time, the firm saw only one criminal case every four to five years, partner Jonathan Kahan told the Association of Medical Diagnostic Manufacturers last week. The first inkling that the FDA was getting tough with industry came in late 1999 when the agency won a consent order against Abbott Laboratories for the company's repeated quality systems violations.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.